211 At-labeled agents for alpha-immunotherapy: On the in vivo stability of astatine-agent bonds

Abstract : The application of 211 At to targeted cancer therapy is currently hindered by the rapid deastatination that occurs in vivo. As the deastatination mechanism is unknown, we tackled this issue from the viewpoint of the intrinsic properties of At-involving chemical bonds. An apparent correlation has been evidenced between in vivo stability of 211 At-labeled compounds and the AtÀR (R ¼ C, B) bond enthalpies obtained from relativistic quantum mechanical calculations. Furthermore, we highlight important differences in the nature of the AtÀC and AtÀB bonds of interest, e.g. the opposite signs of the effective astatine charges, which implies different stabilities with respect to the biological medium. Beyond their practical use for rationalizing the labeling protocols used for 211 At, the proposed computational approach can readily be used to investigate bioactive molecules labeled with other heavy radionuclides.
Type de document :
Article dans une revue
European Journal of Medicinal Chemistry, Elsevier, 2016, 116, pp.156 - 164. 〈10.1016/j.ejmech.2016.03.082〉
Liste complète des métadonnées

Littérature citée [69 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01414904
Contributeur : Elizabeth Bernardo <>
Soumis le : lundi 12 décembre 2016 - 16:33:30
Dernière modification le : vendredi 22 juin 2018 - 09:33:38
Document(s) archivé(s) le : mardi 28 mars 2017 - 00:36:53

Fichier

 Accès restreint
Fichier visible le : jamais

Connectez-vous pour demander l'accès au fichier

Identifiants

Citation

Tahra Ayed, Julien Pilmé, David Tézé, Fadel Bassal, Jacques Barbet, et al.. 211 At-labeled agents for alpha-immunotherapy: On the in vivo stability of astatine-agent bonds. European Journal of Medicinal Chemistry, Elsevier, 2016, 116, pp.156 - 164. 〈10.1016/j.ejmech.2016.03.082〉. 〈inserm-01414904〉

Partager

Métriques

Consultations de la notice

171